Table A4. Government Performance and Results Act (GPRA) Sexually Transmitted Diseases Goals and Measures
| GPRA Goals | Baseline | Actual Performance | Long-Term Goal | ||||
|---|---|---|---|---|---|---|---|
| 2002 | 2008 | 2009 | 2010** | ||||
| Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15–44-years of age) | 197,000 | 104,000 | 100,000 | 94,000 | |||
| a. Prevalence of chlamydia in women ≤25 years at high-risk* | 10.1% | 12.8% | 11.3% | 12.0% | |||
| b. Prevalence of chlamydia in women ≤25 years in family planning clinics* | 5.6% | 7.4% | 7.5% | 7.9% | |||
| c. Incidence of gonorrhea/100, 000 population in women 15–44 years of age | 278 | 285 | 255 | 288 | |||
| Goal 2: Elimination of Syphilis (as measured by incidence of P&S Syphilis/100,000 population) | 2.4 | 4.5 | 4.6 | 5.5 | |||
| a. Incidence of P&S syphilis/100, 000 population, men | 3.8 | 7.6 | 7.8 | 9.4 | |||
| b. Incidence of P&S syphilis/100, 000 population, women | 1.1 | 1.5 | 1.4 | 2.0 | |||
| c. Incidence of congenital syphilis/100, 000 live births | 10.2 | 10.1 | 10.0 | 16.2 | |||
| d. Black:white rate ratio of P&S syphilis | 8:1 | 8:1 | 9:1 | 9:1 | |||
| GPRA Goals | Data Source |
|---|---|
| 1 | National Disease and Therapeutic Index (IMS Health) |
| 1–a | National Job Training Program |
| 1–b | Regional Infertility Prevention Projects (IPP), STD Surveillance System (STDSS), NCHHSTP, CDC |
| 1–c | STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2 | STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2–a | STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2–b | STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2–c | STD Surveillance System (STDSS), NCHHSTP, CDC |
| 2–d | STD Surveillance System (STDSS), NCHHSTP, CDC |
* Median state-specific chlamydia prevalence/positivity.
** Reflects 05/25/2011 modification to Long-Term 2010 GPRA Goals.
GPRA = Government Performance and Results Act; PID = pelvic inflammatory disease; P&S = primary and secondary.
